Overexpression of RHAMM in prostate cancer cells increased phosphorylation of ROCKII and coflin with an accompanying increase in filopodia formation and EMT markers, vimentin and N-cadherin, and a decrease in E- cadherin (50). Here, VIM is linked to prostate cancer.